Vimarsana
Biggest News Aggregation in the World

Page 12 - Antipsychotics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antipsychotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antipsychotics Today - Breaking & Trending Today

Antipsychotic Use in Pregnancy: New Data - Vimarsana News

Antipsychotic Use in Pregnancy: New Data

New data suggest that antipsychotics are not major teratogens, providing additional reassurance for pregnant women who need these medications.

Antipsychotic Shows Benefit for Alzheimer's Agitation - Vimarsana News

Antipsychotic Shows Benefit for Alzheimer's Agitation

Researchers reported that a phase 3 study showed statistically significant improvement in patients with agitation related to Alzheimer's who took the atypical antipsychotic brexpiprazole.

Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study - Vimarsana News

Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study

Author summary Why was this study done? Compared to Alzheimer’s disease (AD), dementia with Lewy bodies (DLBs) is associated with accelerated cognitive decline, lower quality of life, higher caregiver burden, shorter lifespan, and higher costs of care, as well as increased rates of admission to general hospitals and residential care and longer length of stay. Although there are no disease-modifying medications for DLB, there is evidence suggesting that acetylcholinesterase inhibitors (AChEIs) and glutamate N-methyl-D-aspartate receptor antagonists (specifically, memantine) are efficaci...

Source: plos.org
Pervasive Industry Influence in Healthcare Sector Harms Patients - Vimarsana News

Pervasive Industry Influence in Healthcare Sector Harms Patients

Experts point to the harms of drug companies’ influence on research, practice, and education in healthcare.

Dopamine Dysregulation a Causative Culprit in Schizophrenia? - Vimarsana News

Dopamine Dysregulation a Causative Culprit in Schizophrenia?

A genetic postmortem analysis of the brains of patients with schizophrenia suggests the dysfunction of dopamine receptors in the caudate nucleus may play a role in causing cause the disorder.